GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Deferred Tax

Ribomic (TSE:4591) Deferred Tax : 円0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ribomic Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Ribomic's change in deferred tax for the three months ended in Sep. 2024 was 円0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.00 Mil.

Ribomic Deferred Tax Historical Data

The historical data trend for Ribomic's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Deferred Tax Chart

Ribomic Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ribomic Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ribomic Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Deferred Tax Related Terms

Thank you for viewing the detailed overview of Ribomic's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Ribomic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Deferred Tax
Comparable Companies
TSE:4594 TSE:4570 TSE:4576 TSE:4598 TSE:130A TSE:4881 TSE:2385 TSE:2342 TSE:4572 TSE:4596 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Website
http://www.ribomic.com
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic Headlines

No Headlines